Browse Category

Investing News 16 December 2025

Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 2026: What Investors Need to Know on Dec. 16, 2025

Bristol-Myers Squibb (BMY) Stock Jumps on Analyst Upgrades, Dividend Hike, and a Catalyst-Rich 2026: What Investors Need to Know on Dec. 16, 2025

Bristol-Myers Squibb Company (NYSE: BMY) is back in the spotlight on December 16, 2025, with the stock trading around $54.29, up roughly 3.6% on the session as optimism builds around Wall Street upgrades, a newly announced dividend increase, and a steady drumbeat of pipeline and regulatory updates heading into 2026. Smartkarma While BMY has spent much of the past year…
Venus Concept Inc. (NASDAQ: VERO) Stock: Latest News, Catalysts, and Forecasts as of December 16, 2025

Venus Concept Inc. (NASDAQ: VERO) Stock: Latest News, Catalysts, and Forecasts as of December 16, 2025

Venus Concept Inc. stock (NASDAQ: VERO) is back on traders’ radar in mid-December 2025—less because it’s a calm, steadily compounding story (it isn’t), and more because the company has stacked multiple high-impact catalysts and balance-sheet developments into a tight window. As of the Dec. 15 close, VERO finished around $1.67, down roughly 10.7% on the day, and early Dec. 16…
Nektar Therapeutics Stock (NKTR) Surges Into a Major Catalyst: What to Know Ahead of Today’s REZOLVE-AA Data

Nektar Therapeutics Stock (NKTR) Surges Into a Major Catalyst: What to Know Ahead of Today’s REZOLVE-AA Data

Nektar Therapeutics (NASDAQ: NKTR) is in classic “biotech catalyst mode” on December 16, 2025—the kind of day when a single dataset can rewrite a stock chart in minutes. Shares climbed in pre-market and overnight trading as investors positioned for topline results from the 36-week induction period of Nektar’s Phase 2b REZOLVE-AA study in severe-to-very-severe alopecia areata, featuring its lead investigational…
Immunome (IMNM) Stock Today: Phase 3 RINGSIDE Win, $400M Offering, and Fresh Analyst Targets (Dec. 16, 2025)

Immunome (IMNM) Stock Today: Phase 3 RINGSIDE Win, $400M Offering, and Fresh Analyst Targets (Dec. 16, 2025)

Immunome, Inc. (NASDAQ: IMNM) is in the spotlight on December 16, 2025, after the company reported positive topline Phase 3 results for its lead desmoid tumor program and then moved to raise significant new capital—two catalysts that can push a biotech stock in opposite directions at the same time. On the one hand: a clear late-stage efficacy win that supports…
iRobot Stock (IRBT) Plunges After Chapter 11 Bankruptcy Filing: Picea Deal, Nasdaq Delisting Date, and Investor Outlook (Dec. 16, 2025)

iRobot Stock (IRBT) Plunges After Chapter 11 Bankruptcy Filing: Picea Deal, Nasdaq Delisting Date, and Investor Outlook (Dec. 16, 2025)

iRobot Corporation (NASDAQ: IRBT) — the company that turned “Roomba” into a household verb — is now at the center of a market event investors don’t forget: a pre-packaged Chapter 11 bankruptcy process paired with a deal that hands ownership to its lender and key supplier, Shenzhen PICEA Robotics (Picea). The headline is simple, but the implications for iRobot stock…
AMC Robotics Corporation Stock (NASDAQ: AMCI): Latest News, Price Action, and Forecast Outlook on Dec. 16, 2025

AMC Robotics Corporation Stock (NASDAQ: AMCI): Latest News, Price Action, and Forecast Outlook on Dec. 16, 2025

December 16, 2025 — AMC Robotics Corporation stock (NASDAQ: AMCI) has become one of the market’s loudest tickers this week, after a dramatic surge and extreme intraday swings following its recent transition into a newly listed public company. As of the latest consolidated pricing available early Dec. 16 (UTC), AMCI last traded around $7.27, after opening near $3.62 and swinging…
Macquarie Group Ltd (ASX: MQG) Stock News Today: Share Price Action, Dividend Countdown, and Analyst Forecasts (16 December 2025)

Macquarie Group Ltd (ASX: MQG) Stock News Today: Share Price Action, Dividend Countdown, and Analyst Forecasts (16 December 2025)

Macquarie Group Ltd (ASX: MQG) shares hovered around the psychologically important A$200 level on Tuesday, 16 December 2025, as investors weighed a near-term income catalyst (the interim dividend payment due 17 December) against mixed technical signals and a still-active debate on how quickly earnings can re-accelerate in FY26. StockAnalysis For market watchers, the story today is less about a single…
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 16.12.2025

{“@context”:”https://schema.org”,”@type “:”LiveBlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-16-12-2025/#live”,”headline”:”Stock Market Today 16.12.2025″,”description”:”Live rolling coverage of technology news: AI, chips, gadgets, software, startups, cybersecurity, telecom, and policy.”,”datePublished”:”2025-12-16T00:00:02-05:00″,”dateModified”:”2025-12-17T00:00:03-05:00″,”coverageStartTime”:”2025-12-16T00:00:02-05:00″,”coverageEndTime”:”2025-12-17T00:00:03-05:00″,”author”:{“@type”:”Organization”,”name”:”TechStock²”},”publisher”:{“@type”:”Organization”,”name”:”TechStock²”,”logo”:{“@type”:”ImageObject”,”url”:”https://ts2.tech/wp-content/uploads/2024/02/cropped-ts2-logo-google.png”}},”inLanguage”:”en-US”,”liveBlogUpdate”:[{“@type”:”BlogPosting”,”@id”:”https://ts2.tech/en/stock-market-today-16-12-2025/#live/u/0e7108f3f59e05dc”,”headline”:”Tesla Q4 Delivery Preview: Slower Demand Ahead, Yet the Stock Stays Resilient”,”articleBody”:”Tesla is slated to report Q4 deliveries around 400,000-455,000, with Wall Street consensus near ~450k. The preview shows a slowdown after a strong prior quarter, reflecting broader EV demand softness, macro…
IonQ (IONQ) Stock After Hours: Why Shares Fell on Dec. 15, 2025—and What to Watch Before the Market Opens Dec. 16

IonQ (IONQ) Stock After Hours: Why Shares Fell on Dec. 15, 2025—and What to Watch Before the Market Opens Dec. 16

IonQ, Inc. (NYSE: IONQ) ended Monday’s session sharply lower and stayed soft in extended trading, as investors digested a cluster of insider Form 4 filings alongside fresh news highlighting intensifying global competition in quantum computing. Below is a clear, publication-ready breakdown of what happened after the bell on Monday, December 15, 2025, what’s driving the move, and what to keep…
Bristol-Myers Squibb (BMY) Stock After Hours: BofA Upgrade Sparks a Rally — What to Know Before the Market Opens Dec. 16, 2025

Bristol-Myers Squibb (BMY) Stock After Hours: BofA Upgrade Sparks a Rally — What to Know Before the Market Opens Dec. 16, 2025

Bristol-Myers Squibb Company (NYSE: BMY) is ending Monday’s session in the spotlight after a sharp, analyst-driven move that pushed the pharma giant higher into the close — and kept the shares firm in extended trading. After the closing bell on Monday, December 15, 2025, BMY was up about 3.6% in regular trading and added roughly another 0.6% after hours, as…
DroneShield Share Price Rebounds on ASX After 75% Collapse: What’s Driving the Volatility and the Big 2026 Debate

DroneShield Share Price Rebounds on ASX After 75% Collapse: What’s Driving the Volatility and the Big 2026 Debate

DroneShield’s rollercoaster year delivered another jolt on Monday, 15 December 2025, as the Australian counter-drone specialist surged to the top of the ASX 200 leader board even while the broader market slipped. The S&P/ASX 200 closed down 0.72%, dragged by weakness in materials, but DroneShield shares jumped 10.58% to $2.30 in a sharp rebound move. The Economic Times The bounce…
Snowflake (SNOW) Stock After Hours on Dec. 15, 2025: What Investors Need to Know Before the Market Opens Dec. 16

Snowflake (SNOW) Stock After Hours on Dec. 15, 2025: What Investors Need to Know Before the Market Opens Dec. 16

Snowflake Inc. (NYSE: SNOW) ended Monday, December 15, 2025, lower in regular trading and ticked down further in after-hours action as investors continued to digest the company’s early-December earnings reset and a broader market debate about AI-era software margins. Below is a detailed look at SNOW’s after-the-bell move, the most relevant news and forecasts published/updated today, and the key catalysts…
1 374 375 376 377 378 571

Stock Market Today

  • Super Bowl Prediction Markets Sidestep Sports Betting Bans in California
    February 5, 2026, 7:44 AM EST. Prediction market platforms like Kalshi and Polymarket enable sports wagering in states banning traditional sportsbooks, including California. These platforms let users trade event contracts rather than place conventional bets, creating a legal gray area as they avoid acting as the 'house' while charging fees. Kalshi reported $161 million in Super Bowl market trading volume, a sixfold rise from last year. Critics question if these contracts amount to repackaged gambling, referencing California's century-old law prohibiting betting on sports. Industry advocates argue these markets are federally regulated financial exchanges distinct from traditional sportsbooks, allowing traders to buy and sell positions until outcomes settle. Legal experts suspect courts will allow this activity to continue for years amid regulatory uncertainty.
Go toTop